Ro
A direct-to-patient telehealth service in the U.S. that provides online doctor visits, prescriptions, lab testing and home delivery of medication. Services cover men's and women's health, smoking cessation and weight management, including GLP-1 medications, under brands such as Roman.
Health & biotechTelehealth and online pharmacyNew York, United States
FoundersSince 2017
- Valuation
- $7.0B
- Total raised
- $1.0B
- Last round · Feb 2022
- Funding round
- Founded
- 2017
- Quarters in VP50
- 6
Valuation
| Round | Date | Post-money valuation | Raised | Led by |
|---|---|---|---|---|
| Series A | Sep 18, 2018 | $154M | $88M | FirstMark Capital |
| Series B | Apr 15, 2019 | $500M | $85M | Unknown |
| Series C | Jul 27, 2020 | $1.5B | $200M | General Catalyst |
| Series D | Mar 22, 2021 | $5.0B | $500M | FirstMark Capital, General Catalyst, and TQ Ventures |
| Funding round | Feb 15, 2022 | $7.0B | $150M | ShawSpring Partners |
Post-money valuation at each priced round. Log scale.Hover a point for the round
Updated
In VP50
- Q4 2023: no place
- Q1 2024: no place
- Q2 2024: no place
- Q3 2024: no place
- Q4 2024: no place
- Q1 2025: no place
- Q2 2025: no place
- Q3 2025: no place
- Q4 2025: no place
- Q1 2026: no place
- Q2 2026: no place
- Q3 2026: no place
- Q4 2026: no place
Place by quarter since Q4 2023. Best place #9, in Q2 2021.
Funding rounds
DateRound · leadRaisedValuation
Apr 15, 2019Series B$85M$500M
